Abstract 18349: A Pilot Study to Evaluate the Feasibility and Safety of Transendocardial CD34+ Cell Therapy in Heart Failure With Preserved Ejection Fraction

Bojan Vrtovec,Gregor Poglajen,Gregor Zemljic,Matjaz Sever,Marko Cukjati,S. Frljak,Andraž Cerar,R. Okrajšek,Peter Cernelc,Francois Haddad,Joseph C. Wu

Abstract 18349: A Pilot Study to Evaluate the Feasibility and Safety of Transendocardial CD34+ Cell Therapy in Heart Failure With Preserved Ejection Fraction

2016

Bojan Vrtovec
Gregor Poglajen
Gregor Zemljic
Matjaz Sever
Marko Cukjati
S. Frljak
Andraž Cerar
R. Okrajšek
Peter Cernelc
Francois Haddad
Joseph C. Wu

Introduction: To date, no clinical trials of cell therapy in heart failure with preserved ejection fraction (HFpEF) have been performed. Hypothesis: We sought to investigate the safety and feasibil...

Keywords:

Clinical trial
CD34
Heart failure with preserved ejection fraction
Cardiology
Internal medicine
Cell therapy
Diabetes mellitus
Heart failure
Medicine
cd34 cells

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations